Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing

Medicare Part D is a voluntary outpatient prescription drug benefit for people with Medicare provided through private plans, including stand-alone prescription drug plans and Medicare Advantage plans that offer drug coverage. This analysis provides an overview of Medicare Part D plan availability, premiums, and cost sharing in 2025 and key trends over time.

Read More

Experian Health’s High-Performance Summit (HPS) 2024 Recap

Experian Health’s High-Performance Summit (HPS) 2024 was the ultimate gathering for clients to connect, collaborate, and unlock the full potential of Experian Health solutions. Set in the vibrant “Lone Star State,” this exclusive client event brought together industry leaders to tackle some of healthcare’s biggest challenges, from cutting costs to revolutionizing financial and administrative outcomes….

Read More

El plan del gobernador de Florida para importar medicamentos más baratos de Canadá sigue en la nada

Casi un año después que la administración Biden diera luz verde a Florida para convertirse en el primer estado en importar medicamentos recetados más baratos de Canadá —un objetivo de muchos políticos de todas las tendencias, incluido el presidente electo Donald Trump— el programa aún no ha comenzado. El gobernador de Florida, Ron DeSantis, celebró…

Read More

TV’s Dr. Oz Invested in Businesses Regulated by Agency Trump Wants Him To Lead

President-elect Donald Trump’s choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace — celebrity doctor Mehmet Oz — recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Oz’s holdings, some shared with family, included a stake in UnitedHealth…

Read More

5 Healthcare CEOs React to Dr. Oz’s CMS Appointment

President-Elect Donald Trump nominated celebrity physician Dr. Mehmet Oz to lead CMS. Healthcare leaders have mixed feelings on the news — for instance, one CEO pointed out that Dr. Oz could advance the food-as-medicine movement, and others noted that his appointment may decrease pharmaceutical innovation and access to certain medications. The post 5 Healthcare CEOs…

Read More